BioPharma
Daewoong Pharmaceutical (CEO Sengho Jeon & Changjae Lee) recently announced that it has submitted the New Drug Application (NDA) for a n...
March 29, 2022 | News
Furthermore, it also empowers the domestic precision immunotherapy for tumors and promotes the high-quality development of China's biopharmaceuti...
March 28, 2022 | News
DTX-021 is a botulinum toxin type A drug intended for the treatment of moderate to severe glabellar lines. DTX-021 is a highly purified and clinically test...
March 25, 2022 | News
Under the agreement, both companies will collaborate to develop next-generation mRNA-based antibody therapeutics by utilizing the proprietary mRNA platform...
March 22, 2022 | News
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), today announced that it has entered into an agreem...
March 21, 2022 | News
Under the terms of the agreement, Lynk Pharmaceuticals is responsible for the development of the product. Simcere will obtain the exclusive rights to marke...
March 18, 2022 | News
Under the agreement, both companies will conduct collaborative research utilizing NuclixBio's proprietary circular mRNA platform named 'ringRNA™' to ...
March 15, 2022 | News
Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical u...
March 14, 2022 | News
Veristat, a scientific-minded global clinical research organization (CRO), announced today the expansion and strengthening of its service capabilities by a...
March 08, 2022 | News
First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...
March 03, 2022 | News
German independent research institute BioMed X announces today the start of its new research project ‘Advanced Biomarker Detection for Phar...
March 01, 2022 | News
Terumo Health Outcomes, a division of Terumo Medical Corporation, a leading global medical device manufacturer, has signed a collaboration and co-marketing...
February 28, 2022 | News
During the three-year collaboration, multiple undisclosed targets (including undruggable targets) were screened against HitGen's proprietary DNA encoded ch...
February 25, 2022 | News
Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and bi...
February 18, 2022 | News
Most Read
Bio Jobs
News
Editor Picks